GENENCOR INTERNATIONAL INC
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: GENENCOR INTERNATIONAL INC, 10-Q, EX-11, 2000-11-14
Next: FIRST FEDERAL BANCSHARES INC /DE, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM GENENCOR
INTERNATIONAL, INC.'S QUARTERLY REPORT ON FORM 10-Q FOR THE PERIOD ENDED
SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         193,561
<SECURITIES>                                     1,264
<RECEIVABLES>                                   49,950
<ALLOWANCES>                                     2,543
<INVENTORY>                                     44,896
<CURRENT-ASSETS>                               299,997
<PP&E>                                         368,880
<DEPRECIATION>                                 164,852
<TOTAL-ASSETS>                                 621,984
<CURRENT-LIABILITIES>                           63,177
<BONDS>                                        144,737
                          153,382
                                          0
<COMMON>                                           599
<OTHER-SE>                                     236,276
<TOTAL-LIABILITY-AND-EQUITY>                   621,984
<SALES>                                        227,625
<TOTAL-REVENUES>                               240,118
<CGS>                                          129,756
<TOTAL-COSTS>                                  129,756
<OTHER-EXPENSES>                                65,391
<LOSS-PROVISION>                                   584
<INTEREST-EXPENSE>                               7,878
<INCOME-PRETAX>                                 37,093
<INCOME-TAX>                                    11,109
<INCOME-CONTINUING>                             25,984
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    25,984
<EPS-BASIC>                                        .39
<EPS-DILUTED>                                      .37


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission